Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Influenza

Free Subscription Articles published in Vaccine Retrieve available abstracts of 249 articles: HTML format

Single Articles

April 2008
1. DU N , Li W, Li Y, Liu S, et al
   Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
   Vaccine. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
2. SHOJI Y , Chichester JA, Bi H, Musiychuk K, et al
   Plant-expressed HA as a seasonal influenza vaccine candidate.
   Vaccine. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
3. CHAN SS
   Influenza vaccination for healthcare workers: Is it really as effective as we claim?
   Vaccine. 2008;.
   PubMed     Related articles   
   
   
   
4. NORTON SP , Scheifele DW, Bettinger JA, West RM, et al
   Influenza vaccination in paediatric nurses: Cross-sectional study of coverage, refusal, and factors in acceptance.
   Vaccine. 2008;.
   PubMed     Related articles    Abstract available
   
   
   March 2008
5. ABRAMSON ZH , Levi O
   Influenza vaccination among primary healthcare workers.
   Vaccine. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
6. ROSAS C , Van de Walle GR, Metzger SM, Hoelzer K, et al
   Evaluation of a vectored equine herpesvirus type 1 (EHV-1) vaccine expressing H3 haemagglutinin in the protection of dogs against canine influenza.
   Vaccine. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
7. SUGIMURA T , Ito Y, Tananari Y, Ozaki Y, et al
   Improved antibody responses in infants less than 1 year old using intradermal influenza vaccination.
   Vaccine. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
8. HAYNEY MS , Moran J, Wiegert NA, Burlingham WJ, et al
   Lung transplant patients' T cell responses to influenza vaccine viruses between seasons.
   Vaccine. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
9. WILLIAMS TL , Luna L, Guo Z, Cox NJ, et al
   Quantification of influenza virus hemagglutinins in complex mixtures using isotope dilution tandem mass spectrometry.
   Vaccine. 2008;26:2510-2520.
   PubMed     Related articles    Abstract available
   
   
   
10. GIRARD MP , Osterhaus A, Pervikov Y, Palkonyay L, et al
    Report of the third meeting on "Influenza vaccines that induce broad spectrum and long-lasting immune responses", World Health Organization, Geneva, Switzerland, 3-4 December 2007.
    Vaccine. 2008;.
    PubMed     Related articles   
    
    
    
11. PALACHE AM , Beyer WE, Osterhaus AD
    Influenza vaccine dosages.
    Vaccine. 2008;.
    PubMed     Related articles   
    
    
    
12. DE MARE A , Bungener LB, Regts J, de Vries-Idema J, et al
    The effect of pre-existing immunity on the capacity of influenza virosomes to induce cytotoxic T lymphocyte activity.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
13. MINNE A , Huaux F, Jaworska J, Rha RD, et al
    Safety evaluation of pulmonary influenza vaccination in healthy and "asthmatic" mice.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
14. BUNGENER L , Geeraedts F, Ter Veer W, Medema J, et al
    Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
15. ROMER-OBERDORFER A , Veits J, Helferich D, Mettenleiter TC, et al
    Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
16. TORO H , Tang DC, Suarez DL, Zhang J, et al
    Protection of chickens against avian influenza with non-replicating adenovirus-vectored vaccine.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
17. ILYINSKII PO , Meriin AB, Gabai VL, Zhirnov OP, et al
    Prime-boost vaccination with a combination of proteosome-degradable and wild-type forms of two influenza proteins leads to augmented CTL response.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
18. HOLMAN DH , Wang D, Raja NU, Luo M, et al
    Multi-antigen vaccines based on complex adenovirus vectors induce protective immune responses against H5N1 avian influenza viruses.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
19. LO CY , Wu Z, Misplon JA, Price GE, et al
    Comparison of vaccines for induction of heterosubtypic immunity to influenza A virus: Cold-adapted vaccine versus DNA prime-adenovirus boost strategies.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
20. MALTEZOU HC , Maragos A, Katerelos P, Paisi A, et al
    Influenza vaccination acceptance among health-care workers: A nationwide survey.
    Vaccine. 2008;26:1408-10.
    PubMed     Related articles    Abstract available
    
    
    
21. MIZUKAMI T , Imai JI, Hamaguchi I, Kawamura M, et al
    Application of DNA microarray technology to influenza A/Vietnam/1194/2004 (H5N1) vaccine safety evaluation.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    February 2008
22. CO MD , Orphin L, Cruz J, Pazoles P, et al
    Discordance between antibody and T cell responses in recipients of trivalent inactivated influenza vaccine.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
23. SAKABE S , Sakoda Y, Haraguchi Y, Isoda N, et al
    A vaccine prepared from a non-pathogenic H7N7 virus isolated from natural reservoir conferred protective immunity against the challenge with lethal dose of highly pathogenic avian influenza virus in chickens.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
24. NEWALL AT , Scuffham PA, Kelly H, Harsley S, et al
    The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
25. NEWALL AT , Wood JG, Macintyre CR
    Influenza-related hospitalisation and death in Australians aged 50 years and older.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
26. LU P , Bridges CB, Euler GL, Singleton JA, et al
    Influenza vaccination of recommended adult populations, U.S., 1989-2005.
    Vaccine. 2008;26:1786-1793.
    PubMed     Related articles    Abstract available
    
    
    
27. JADHAO SJ , Achenbach J, Swayne DE, Donis R, et al
    Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine.
    Vaccine. 2008;26:1742-1750.
    PubMed     Related articles    Abstract available
    
    
    
28. VEITS J , Romer-Oberdorfer A, Helferich D, Durban M, et al
    Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
29. ANSALDI F , Bacilieri S, Durando P, Sticchi L, et al
    Cross-protection by MF59trade mark-adjuvanted influenza vaccine: Neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    January 2008
30. VAN DEN DOOL C , Van Strien AM, Akker IL, Bonten MJ, et al
    Attitude of Dutch hospital personnel towards influenza vaccination.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
31. ELIASSON DG , Bakkouri KE, Schon K, Ramne A, et al
    CTA1-M2e-DD: A novel mucosal adjuvant targeted influenza vaccine.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
32. RIDDA I , Motbey C, Lam L, Lindley IR, et al
    Factors associated with pneumococcal immunisation among hospitalised elderly persons: a survey of patient's perception, attitude, and knowledge.
    Vaccine. 2008;26:234-40.
    PubMed     Related articles    Abstract available
    
    
    
33. SEO SU , Byun YH, Lee EY, Jung EJ, et al
    Development and characterization of a live attenuated influenza B virus vaccine candidate.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    December 2007
34. YASSINE HM , Lee CW, Suarez DL, Saif YM, et al
    Genetic and antigenic relatedness of H3 subtype influenza A viruses isolated from avian and mammalian species.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
35. KOTWAL GJ
    Genetic diversity-independent neutralization of pandemic viruses (e.g. HIV), potentially pandemic (e.g. H5N1 strain of influenza) and carcinogenic (e.g. HBV and HCV) viruses and possible agents of bioterrorism (variola) by enveloped virus neutralizing co
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
36. SEBASTIAN R , Skowronski DM, Chong M, Dhaliwal J, et al
    Age-related trends in the timeliness and prediction of medical visits, hospitalizations and deaths due to pneumonia and influenza, British Columbia, Canada, 1998-2004.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
37. ZHAN X , Hurwitz JL, Krishnamurthy S, Takimoto T, et al
    Respiratory syncytial virus (RSV) fusion protein expressed by recombinant Sendai virus elicits B-cell and T-cell responses in cotton rats and confers protection against RSV subtypes A and B.
    Vaccine. 2007;25:8782-93.
    PubMed     Related articles    Abstract available
    
    
    
38. GABRIEL G , Garn H, Wegmann M, Renz H, et al
    The potential of a protease activation mutant of a highly pathogenic avian influenza virus for a pandemic live vaccine.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
39. WACK A , Baudner BC, Hilbert AK, Manini I, et al
    Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
40. STEEL J , Burmakina SV, Thomas C, Spackman E, et al
    A combination in-ovo vaccine for avian influenza virus and Newcastle disease virus.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
41. ITOH Y , Ozaki H, Tsuchiya H, Okamoto K, et al
    A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    November 2007
42. MCMAHON AW , Iskander JK, Haber P, Braun MM, et al
    Inactivated influenza vaccine (IIV) in children <2 years of age: Examination of selected adverse events reported to the Vaccine Adverse Event Reporting System (VAERS) after thimerosal-free or thimerosal-containing vaccine.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
43. CHEN Z , Aspelund A, Jin H
    Stabilizing the glycosylation pattern of influenza B hemagglutinin following adaptation to growth in eggs.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
44. VAN DER SANDE MA , van Asten L, Straus SM, Schim van der Loeff MF, et al
    Sudden deaths following influenza vaccination: Can this be expected?
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
45. HULEATT JW , Nakaar V, Desai P, Huang Y, et al
    Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
46. DE BRUIJN I , Meyer I, Gerez L, Nauta J, et al
    Antibody induction by virosomal, MF59-adjuvanted, or conventional influenza vaccines in the elderly.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
47. SCHMIDT-OTT R , Schwarz T, Haase R, Sander H, et al
    Immunogenicity and reactogenicity of a trivalent influenza split vaccine in previously unvaccinated children aged 6-9 and 10-13 years.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
48. AMORIJ JP , Westra TA, Hinrichs WL, Huckriede A, et al
    Towards an oral influenza vaccine: Comparison between intragastric and intracolonic delivery of influenza subunit vaccine in a murine model.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    October 2007
49. KOKIA ES , Silverman BG, Green M, Kedem H, et al
    Deaths following influenza vaccination-background mortality or causal connection?
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
50. AMORIJ JP , Saluja V, Petersen AH, Hinrichs WL, et al
    Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB/c mice.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
51. WU F , Huang JH, Yuan XY, Huang WS, et al
    Characterization of immunity induced by M2e of influenza virus.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
52. ZENG R , Qi X, Gong W, Mei X, et al
    Long-lasting balanced immunity and protective efficacy against respiratory syncytial virus in mice induced by a recombinant protein G1F/M2.
    Vaccine. 2007;25:7422-8.
    PubMed     Related articles    Abstract available
    
    
    
53. LAU JT , Kim JH, Choi KC, Tsui HY, et al
    Changes in prevalence of influenza vaccination and strength of association of factors predicting influenza vaccination over time-Results of two population-based surveys.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
54. OKAMOTO S , Yoshii H, Akagi T, Akashi M, et al
    Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
55. VAN DER GOOT JA , van Boven M, Koch G, de Jong MC, et al
    Variable effect of vaccination against highly pathogenic avian influenza (H7N7) virus on disease and transmission in pheasants and teals.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
56. ELLIOTT MB , Chen T, Terio NB, Chong SY, et al
    Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques.
    Vaccine. 2007;25:7132-44.
    PubMed     Related articles    Abstract available
    
    
    
57. HUBBY B , Talarico T, Maughan M, Reap EA, et al
    Development and preclinical evaluation of an alphavirus replicon vaccine for influenza.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
58. LEE MS , Chen MC, Liao YC, Hsiung CA, et al
    Identifying potential immunodominant positions and predicting antigenic variants of influenza A/H3N2 viruses.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    September 2007
59. HOLM MV , Blank PR, Szucs TD
    Developments in influenza vaccination coverage in England, Scotland and Wales covering five consecutive seasons from 2001 to 2006.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
60. VINCENT AL , Ma W, Lager KM, Janke BH, et al
    Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
61. HIBBERT CL , Piedra PA, McLaurin KK, Vesikari T, et al
    Cost-effectiveness of live-attenuated influenza vaccine, trivalent in preventing influenza in young children attending day-care centres.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
62. JORDAN RE , Hawker JI, Ayres JG, Tunnicliffe W, et al
    A case-control study of elderly patients with acute respiratory illness: Effect of influenza vaccination on admission to hospital in winter 2003-2004.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
63. ARNOUX S , Weinberger C, Gessner BD
    Vaccine-preventable influenza disease burden from clinical trials of Vaxigrip - an inactivated split virion influenza vaccine - supports wider vaccine use.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
64. SEO SU , Lee KH, Byun YH, Kweon MN, et al
    Immediate and broad-spectrum protection against heterologous and heterotypic lethal challenge in mice by live influenza vaccine.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
65. BENOIT AC , Huang Y, Maneewatchararangsri S, Tapchaisri P, et al
    Regulation of airway eosinophil and neutrophil infiltration by alpha-galactosylceramide in a mouse model for respiratory syncytial virus (RSV) vaccine-augmented disease.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
66. COUCH RB , Winokur P, Brady R, Belshe R, et al
    Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
67. XIE H , Liu T, Chen H, Huang X, et al
    Evaluating the vaccine potential of an influenza A viral hemagglutinin and matrix double insertion DNA plasmid.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
68. CONCEICAO MM , Tonso A, Freitas CB, Pereira CA, et al
    Viral antigen production in cell cultures on microcarriers Bovine parainfluenza 3 virus and MDBK cells.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
69. PARIDA R , Shaila MS, Mukherjee S, Chandra NR, et al
    Computational analysis of proteome of H5N1 avian influenza virus to define T cell epitopes with vaccine potential.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
70. BARQUERO N , Daly JM, Newton JR
    Risk factors for influenza infection in vaccinated racehorses: Lessons from an outbreak in Newmarket, UK in 2003.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
71. COUPLAND C , Harcourt S, Vinogradova Y, Smith G, et al
    Inequalities in uptake of influenza vaccine by deprivation and risk group: Time trends analysis.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
72. PAILLOT R , Kydd JH, Macrae S, Minke JM, et al
    New assays to measure equine influenza virus-specific Type 1 immunity in horses.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
73. PUIG-BARBERA J , Diez-Domingo J, Varea AB, Chavarri GS, et al
    Effectiveness of MF59trade mark-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    August 2007
74. VAWTER DE , Gervais KG, Garrett JE
    Allocating pandemic influenza vaccines in Minnesota: Recommendations of the Pandemic Influenza Ethics Work Group.
    Vaccine. 2007;25:6522-36.
    PubMed     Related articles    Abstract available
    
    
    
75. WRIGHT PF , Karron RA, Belshe RB, Shi JR, et al
    The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
76. SHI H , Liu XF, Zhang X, Chen S, et al
    Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
77. TERNETTE N , Tippler B, Uberla K, Grunwald T, et al
    Immunogenicity and efficacy of codon optimized DNA vaccines encoding the F-protein of respiratory syncytial virus.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
78. NOLAN SM , Skiadopoulos MH, Bradley K, Kim OS, et al
    Recombinant human parainfluenza virus type 2 vaccine candidates containing a 3' genomic promoter mutation and L polymerase mutations are attenuated and protective in non-human primates.
    Vaccine. 2007;25:6409-22.
    PubMed     Related articles    Abstract available
    
    
    
79. QUINLIVAN M , Nelly M, Prendergast M, Breathnach C, et al
    Pro-inflammatory and antiviral cytokine expression in vaccinated and unvaccinated horses exposed to equine influenza virus.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
80. ROY S , Kobinger GP, Lin J, Figueredo J, et al
    Partial protection against H5N1 influenza in mice with a single dose of a chimpanzee adenovirus vector expressing nucleoprotein.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
81. ABALLEA S , De Juanes JR, Barbieri M, Martin M, et al
    The cost effectiveness of influenza vaccination for adults aged 50 to 64 years: A model-based analysis for Spain.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
82. CARRAT F , Flahault A
    Influenza vaccine: The challenge of antigenic drift.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    July 2007
83. BOS JM , Rietveld E, Moll HA, Steyerberg EW, et al
    The use of health economics to guide drug development decisions: Determining optimal values for an RSV-vaccine in a model-based scenario-analytic approach.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
84. VILA-CORCOLES A , Rodriguez T, de Diego C, Ochoa O, et al
    Effect of influenza vaccine status on winter mortality in Spanish community-dwelling elderly people during 2002-2005 influenza periods.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
85. ZUCCOTTI G , Amendola A, Vigano A, Pariani E, et al
    Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
86. BELSHE RB , Newman FK, Wilkins K, Graham IL, et al
    Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
87. AMORIJ JP , Meulenaar J, Hinrichs WL, Stegmann T, et al
    Rational design of an influenza subunit vaccine powder with sugar glass technology: Preventing conformational changes of haemagglutinin during freezing and freeze-drying.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
88. ASANUMA H , Fujihashi K, Miyakoshi T, Yoshikawa T, et al
    Long- and short-time immunological memory in different strains of mice given nasally an adjuvant-combined nasal influenza vaccine.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
89. SONG SK , Moldoveanu Z, Nguyen HH, Kim EH, et al
    Intranasal immunization with influenza virus and Korean mistletoe lectin C (KML-C) induces heterosubtypic immunity in mice.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    June 2007
90. SHARPE M , Lynch D, Topham S, Major D, et al
    Protection of mice from H5N1 influenza challenge by prophylactic DNA vaccination using particle mediated epidermal delivery.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
91. SINGH SR , Dennis VA, Carter CL, Pillai SR, et al
    Immunogenicity and efficacy of recombinant RSV-F vaccine in a mouse model.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
92. HOSHI SL , Kondo M, Honda Y, Okubo I, et al
    Cost-effectiveness analysis of influenza vaccination for people aged 65 and over in Japan.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
93. REDLBERGER M , Aberle SW, Heinz FX, Popow-Kraupp T, et al
    Dynamics of antigenic and genetic changes in the hemagglutinins of influenza A/H3N2 viruses of three consecutive seasons (2002/2003 to 2004/2005) in Austria.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
94. ESPOSITO S , Tremolati E, Bellasio M, Chiarelli G, et al
    Attitudes and knowledge regarding influenza vaccination among hospital health workers caring for women and children.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
95. JAMES CM , Foong YY, Mansfield JP, Fenwick SG, et al
    Use of tetanus toxoid as a differentiating infected from vaccinated animals (DIVA) strategy for sero-surveillance of avian influenza virus vaccination in poultry.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    May 2007
96. OSTERHAUS AD
    Pre- or post-pandemic influenza vaccine?
    Vaccine. 2007;.
    PubMed     Related articles   
    
    
    
97. CYR SL , Jones T, Stoica-Popescu I, Brewer A, et al
    Intranasal proteosome-based respiratory syncytial virus (RSV) vaccines protect BALB/c mice against challenge without eosinophilia or enhanced pathology.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
98. ATMAR RL , Keitel WA, Cate TR, Munoz FM, et al
    A dose-response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
99. YOUN HJ , Ko SY, Lee KA, Ko HJ, et al
    A single intranasal immunization with inactivated influenza virus and alpha-galactosylceramide induces long-term protective immunity without redirecting antigen to the central nervous system.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
100. SKULL SA , Andrews RM, Byrnes GB, Kelly HA, et al
     Missed opportunities to vaccinate a cohort of hospitalised elderly with pneumococcal and influenza vaccines.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
101. GILL TK , Taylor AW, Watson M
     Trends in influenza immunisation amongst an elderly Australian community.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     April 2007
102. SKULL SA , Andrews RM, Byrnes GB, Kelly HA, et al
     Validity of self-reported influenza and pneumococcal vaccination status among a cohort of hospitalized elderly inpatients.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
103. BRIGNONE C , Grygar C, Marcu M, Perrin G, et al
     IMP321 (sLAG-3) safety and T cell response potentiation using an influenza vaccine as a model antigen: A single-blind phase I study.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
104. NAGATA T , Toyota T, Ishigaki H, Ichihashi T, et al
     Peptides coupled to the surface of a kind of liposome protect infection of influenza viruses.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
105. MOLINARI NA , Ortega-Sanchez IR, Messonnier ML, Thompson WW, et al
     The annual impact of seasonal influenza in the US: Measuring disease burden and costs.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
106. ANTONIS AF , van der Most RG, Suezer Y, Stockhofe-Zurwieden N, et al
     Vaccination with recombinant modified vaccinia virus Ankara expressing bovine respiratory syncytial virus (bRSV) proteins protects calves against RSV challenge.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
107. OTSUKA T , Fujinaka H, Katsuyama K, Iizawa M, et al
     Influenza vaccination for severely multiply handicapped persons/children in the 2005-2006 season.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
108. BERTELSEN MF , Klausen J, Holm E, Grondahl C, et al
     Serological response to vaccination against avian influenza in zoo-birds using an inactivated H5N9 vaccine.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
109. GRAY GC , Trampel DW, Roth JA
     Pandemic influenza planning: Shouldn't swine and poultry workers be included?
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
110. MURRIS-ESPIN M , Maitre M, Bosdure E, Dubus JC, et al
     Influenza vaccination in healthcare workers: A survey of coverage in French cystic fibrosis treatment centres.
     Vaccine. 2007;.
     PubMed     Related articles   
     
     
     March 2007
111. HUGHES K , Zachertowska A, Wan S, Li L, et al
     Yield increases in intact influenza vaccine virus from chicken allantoic fluid through isolation from insoluble allantoic debris.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
112. SKULL SA , Andrews RM, Byrnes GB, Kelly HA, et al
     Prevention of community-acquired pneumonia among a cohort of hospitalized elderly: Benefit due to influenza and pneumococcal vaccination not demonstrated.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
113. HALLORAN ME , Piedra PA, Longini IM Jr, Gaglani MJ, et al
     Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
114. OHBA K , Yoshida S, Zahidunnabi Dewan M, Shimura H, et al
     Mutant influenza A virus nucleoprotein is preferentially localized in the cytoplasm and its immunization in mice shows higher immunogenicity and cross-reactivity.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
115. PUSHKO P , Tumpey TM, Van Hoeven N, Belser JA, et al
     Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
116. BALDO V , Baldovin T, Floreani A, Carraro AM, et al
     MF59-adjuvanted influenza vaccine confers superior immunogenicity in adult subjects (18-60 years of age) with chronic diseases who are at risk of post-influenza complications.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
117. OSTERHAUS AD , Vanlangendonck C
     Chapter III. The second European Influenza Conference--lessons learnt and actions to take. The urgent need for a European influenza task force.
     Vaccine. 2007;25:2155-60.
     PubMed     Related articles   
     
     
     February 2007
118. STEPHENSON I , Das RG, Wood JM, Katz JM, et al
     Comparison of neutralising antibody assays for detection of antibody to influenza A/H3N2 viruses: An international collaborative study.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
119. PHILIPPA J , Baas C, Beyer W, Bestebroer T, et al
     Vaccination against highly pathogenic avian influenza H5N1 virus in zoos using an adjuvanted inactivated H5N2 vaccine.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
120. SYLTE MJ , Hubby B, Suarez DL
     Influenza neuraminidase antibodies provide partial protection for chickens against high pathogenic avian influenza infection.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
121. CAPUA I , Marangon S
     The use of vaccination to combat multiple introductions of Notifiable Avian Influenza viruses of the H5 and H7 subtypes between 2000 and 2006 in Italy.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
122. BRIGHT RA , Carter DM, Daniluk S, Toapanta FR, et al
     Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
123. KATZ MA , Tharmaphornpilas P, Chantra S, Dowell SF, et al
     Who gets hospitalized for influenza pneumonia in Thailand? Implications for vaccine policy.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     January 2007
124. NINOMIYA A , Imai M, Tashiro M, Odagiri T, et al
     Inactivated influenza H5N1 whole-virus vaccine with aluminum adjuvant induces homologous and heterologous protective immunities against lethal challenge with highly pathogenic H5N1 avian influenza viruses in a mouse model.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
125. LADDY DJ , Yan J, Corbitt N, Kobasa D, et al
     Immunogenicity of novel consensus-based DNA vaccines against avian influenza.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
126. NAVAS E , Salleras L, Dominguez A, Ibanez D, et al
     Cost-effectiveness analysis of inactivated virosomal subunit influenza vaccination in children aged 3-14 years from the provider and societal perspectives.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
127. MBAWUIKE I , Zang Y, Couch RB
     Humoral and cell-mediated immune responses of humans to inactivated influenza vaccine with or without QS21 adjuvant.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
128. ELLIS JA , Martin BV, Waldner C, Dyer KD, et al
     Mucosal inoculation with an attenuated mouse pneumovirus strain protects against virulent challenge in wild type and interferon-gamma receptor deficient mice.
     Vaccine. 2007;25:1085-95.
     PubMed     Related articles    Abstract available
     
     
     
129. CYR SL , Jones T, Stoica-Popescu I, Burt D, et al
     C57Bl/6 mice are protected from respiratory syncytial virus (RSV) challenge and IL-5 associated pulmonary eosinophilic infiltrates following intranasal immunization with Protollin-eRSV vaccine.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
130. WONG JP , Christopher ME, Salazar AM, Dale RM, et al
     Nucleic acid-based antiviral drugs against seasonal and avian influenza viruses.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
131. JOHANSSON BE , Brett IC
     Changing perspective on immunization against influenza.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
132. POLAND GA , Jacobson RM, Targonski PV
     Avian and pandemic influenza: An overview.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
133. TARGONSKI PV , Jacobson RM, Poland GA
     Immunosenescence: Role and measurement in influenza vaccine response among the elderly.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
134. JIMENEZ-GARCIA R , Carrasco-Garrido P, Hernandez-Barrera V, de Andres AL, et al
     Estimates of influenza vaccination target population sizes in Spain for the 2006-2007 season.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
135. MCNEIL SA , Noya F, Dionne M, Predy G, et al
     Comparison of the safety and immunogenicity of concomitant and sequential administration of an adult formulation tetanus and diphtheria toxoids adsorbed combined with acellular pertussis (Tdap) vaccine and trivalent inactivated influenza vaccine in ad
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
136. DE JUANES JR , Garcia de Codes A, Arrazola MP, Jaen F, et al
     Influenza vaccination coverage among hospital personnel over three consecutive vaccination campaigns (2001-2002 to 2003-2004).
     Vaccine. 2007;25:201-4.
     PubMed     Related articles    Abstract available
     
     
     December 2006
137. WANG M , Lamberth K, Harndahl M, Roder G, et al
     CTL epitopes for influenza A including the H5N1 bird flu; genome-, pathogen-, and HLA-wide screening.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     November 2006
138. ZIMMERMAN RK
     Rationing of influenza vaccine during a pandemic: Ethical analyses.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
139. MONTOMOLI E , Manini I
     Pre-emptive vaccination against pandemic influenza virus.
     Vaccine. 2006;.
     PubMed     Related articles   
     
     
     
140. 
     Influenza as an issue on the agenda of different stakeholders. A multidisciplinary point of view.
     Vaccine. 2006;24.
     PubMed     Related articles    Abstract available
     
     
     
141. 
     Influenza as an issue on the agenda of policy makers and government representatives. What can we do? What do we need?
     Vaccine. 2006;24.
     PubMed     Related articles    Abstract available
     
     
     
142. 
     Influenza as an issue on the agenda of health care workers: what can we do? What do we need?
     Vaccine. 2006;24.
     PubMed     Related articles    Abstract available
     
     
     
143. 
     Diagnosis and treatment of influenza in primary healthcare: "You can't manage what you can't measure".
     Vaccine. 2006;24.
     PubMed     Related articles    Abstract available
     
     
     
144. 
     Recommendations and guidelines on influenza vaccination and treatment. A key success factor.
     Vaccine. 2006;24.
     PubMed     Related articles    Abstract available
     
     
     
145. 
     Misconceptions concerning influenza: an overview and clear answers.
     Vaccine. 2006;24.
     PubMed     Related articles    Abstract available
     
     
     
146. 
     Economic and social impact of epidemic and pandemic influenza.
     Vaccine. 2006;24.
     PubMed     Related articles    Abstract available
     
     
     
147. 
     Influenza surveillance: Why?
     Vaccine. 2006;24.
     PubMed     Related articles    Abstract available
     
     
     
148. 
     Epidemic and pandemic influenza, who cares and how?
     Vaccine. 2006;24.
     PubMed     Related articles    Abstract available
     
     
     
149. 
     Pandemic preparedness: different perspectives. How ready are we for the next pandemic?
     Vaccine. 2006;24.
     PubMed     Related articles    Abstract available
     
     
     
150. 
     How to develop and implement pandemic preparedness plans? The need for a coherent European policy.
     Vaccine. 2006;24.
     PubMed     Related articles    Abstract available
     
     
     
151. 
     Proceedings of the 2nd European Influenza Conference, Malta, 11-14 September 2005.
     Vaccine. 2006;24.
     PubMed     Related articles   
     
     
     
152. HUNGNES O
     Early detection of A/California/7/2004-like A(H3N2) strains in Norway during the 2004-2005 season, and emergence of a novel H3N2 genetic sub-variant toward the end.
     Vaccine. 2006;24.
     PubMed     Related articles    Abstract available
     
     
     
153. BREWSTER M , Smith JR, Dutkowski R, Robson R, et al
     Active metabolite from Tamiflu solution is bioequivalent to that from capsule delivery in healthy volunteers: a cross-over, randomised, open-label study.
     Vaccine. 2006;24.
     PubMed     Related articles    Abstract available
     
     
     
154. CHOWELL G , Ammon CE, Hengartner NW, Hyman JM, et al
     Estimation of the reproductive number of the Spanish flu epidemic in Geneva, Switzerland.
     Vaccine. 2006;24.
     PubMed     Related articles    Abstract available
     
     
     
155. ALEXANDER DJ
     An overview of the epidemiology of avian influenza.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
156. CAPUA I , Marangon S
     Control and prevention of avian influenza in an evolving scenario.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
157. PATEL JA , Nguyen DT, Revai K, Chonmaitree T, et al
     Role of respiratory syncytial virus in acute otitis media: Implications for vaccine development.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     
158. JAMES CM , Abdad MY, Mansfield JP, Jacobsen HK, et al
     Differential activities of alpha/beta IFN subtypes against influenza virus in vivo and enhancement of specific immune responses in DNA vaccinated mice expressing haemagglutinin and nucleoprotein.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     October 2006
159. WANG CS , Wang ST, Lai CT, Lin LJ, et al
     Impact of influenza vaccination on major cause-specific mortality.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
160. KWONG JC , Manuel DG
     Using OHIP physician billing claims to ascertain individual influenza vaccination status.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
161. CHOU CH , Liou WP, Hu KI, Loh CH, et al
     Bell's palsy associated with influenza vaccination: Two case reports.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
162. MUTWIRI G , Benjamin P, Soita H, Townsend H, et al
     Poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) is a potent enhancer of mixed Th1/Th2 immune responses in mice immunized with influenza virus antigens.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
163. SKOWRONSKI DM , Masaro C, Kwindt TL, Mak A, et al
     Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: Results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
164. KWONG JC , Stukel TA, McGeer AJ, Manuel DG, et al
     Appropriate measures of influenza immunization program effectiveness.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
165. BLAY A , Bessler H, Lahad A, Waitman DA, et al
     Does pneumococcal vaccine reduce influenza morbidity in humans?
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
166. RAMET J , Weil-Olivier C, Sedlak W
     Influenza vaccination: The paediatric perspective.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     September 2006
167. KIENY MP , Costa A, Hombach J, Carrasco P, et al
     A global pandemic influenza vaccine action plan.
     Vaccine. 2006;24.
     PubMed     Related articles    Abstract available
     
     
     
168. TORO H , Tang DC, Suarez DL, Sylte MJ, et al
     Protective avian influenza in ovo vaccination with non-replicating human adenovirus vector.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
169. MULLOOLY JP , Bridges CB, Thompson WW, Chen J, et al
     Influenza- and RSV-associated hospitalizations among adults.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
170. OPITZ L , Salaklang J, Buttner H, Reichl U, et al
     Lectin-affinity chromatography for downstream processing of MDCK cell culture derived human influenza A viruses.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
171. KREIJTZ JH , Bodewes R, van Amerongen G, Kuiken T, et al
     Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
172. AUEWARAKUL P , Kositanont U, Sornsathapornkul P, Tothong P, et al
     Antibody responses after dose-sparing intradermal influenza vaccination.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     August 2006
173. PRINCIPI N , Esposito S
     Influenza vaccination in healthy children.
     Vaccine. 2006;.
     PubMed     Related articles   
     
     
     
174. QUAN FS , Compans RW, Cho YK, Kang SM, et al
     Ginseng and Salviae herbs play a role as immune activators and modulate immune responses during influenza virus infection.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
175. GREER CE , Zhou F, Legg HS, Tang Z, et al
     A chimeric alphavirus RNA replicon gene-based vaccine for human parainfluenza virus type 3 induces protective immunity against intranasal virus challenge.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
176. AMIDI M , Romeijn SG, Verhoef JC, Junginger HE, et al
     N-Trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: Biological properties and immunogenicity in a mouse model.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
177. RYAN J , Zoellner Y, Gradl B, Palache B, et al
     Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
178. HERRERA GA , Iwane MK, Cortese M, Brown C, et al
     Influenza vaccine effectiveness among 50-64-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003-2004.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     July 2006
179. THOMAS DR , Mason BW, Beer L, Scourfield S, et al
     Surveillance of influenza immunisation uptake in people aged under 65 years with chronic disease.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
180. RIZZO C , Viboud C, Montomoli E, Simonsen L, et al
     Influenza-related mortality in the Italian elderly: No decline associated with increasing vaccination coverage.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
181. MCBEAN AM , Jung K, Hebert PL
     Decreasing invasive pneumococcal disease in the elderly: a state-level analysis.
     Vaccine. 2006;24.
     PubMed     Related articles    Abstract available
     
     
     June 2006
182. YOO BK , Grosse S, Frick KD
     Self-selection and evaluation of influenza vaccination effectiveness among elderly.
     Vaccine. 2006;.
     PubMed     Related articles   
     
     
     
183. DESHEVA JA , Lu XH, Rekstin AR, Rudenko LG, et al
     Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
184. DE WIT E , Spronken MI, Rimmelzwaan GF, Osterhaus AD, et al
     Evidence for specific packaging of the influenza A virus genome from conditionally defective virus particles lacking a polymerase gene.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
185. RIZZUTO E , Prete AM, Virtuani L, Pompa MG, et al
     Effectiveness of influenza vaccination: A survey within the Italian Ministry of Health personnel.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
186. TREANOR J , Wu H, Liang H, Topham DJ, et al
     Immune responses to vaccinia and influenza elicited during primary versus recent or distant secondary smallpox vaccination of adults.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
187. KONOVALOVA NI , Litvinova OM, Gudkova TM, Lobova TG, et al
     Etiology of influenza viruses isolated in Russia from 1998 up to present time.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
188. BRYDAK LB , Machala M, Centkowski P, Warzocha K, et al
     Humoral response to hemagglutinin components of influenza vaccine in patients with non-Hodgkin malignant lymphoma.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
189. OXFORD JS , Lambkin R, Elliot A, Daniels R, et al
     Scientific lessons from the first influenza pandemic of the 20th century.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
190. WADLE A , Held G, Neumann F, Kleber S, et al
     Cross-presentation of HLA class I epitopes from influenza matrix protein produced in Saccharomyces cerevisiae.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
191. STENQVIST K , Hellvin MA, Hellke P, Hoglund D, et al
     Influenza work on the regional level in Sweden: An integrated program for vaccination of risk groups, surveillance and pandemic planning which focuses on the role of the health care worker.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
192. STRAIGHT TM , Ottolini MG, Prince GA, Eichelberger MC, et al
     Evidence of a cross-protective immune response to influenza A in the cotton rat model.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
193. REKSTIN AR , Kiseleva IV, Klimov AI, Katz JM, et al
     Interferon and other proinflamatory cytokine responses in vitro following infection with wild-type and cold-adapted reassortant influenza viruses.
     Vaccine. 2006;.
     PubMed     Related articles   
     
     
     
194. DE FILETTE M , Fiers W, Martens W, Birkett A, et al
     Improved design and intranasal delivery of an M2e-based human influenza A vaccine.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
195. KURSTEINER O , Moser C, Lazar H, Durrer P, et al
     Inflexal((R)) V-The influenza vaccine with the lowest ovalbumin content.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
196. HAAHEIM LR , Tomasov CC, Barr IG, Hampson AW, et al
     Identification of genetic diversity by cultivating influenza A(H3N2) virus in vitro in the presence of post-infection sera from small children.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
197. FLAHAULT A , Vergu E, Coudeville L, Grais RF, et al
     Strategies for containing a global influenza pandemic.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
198. LEGRAND J , Vergu E, Flahault A
     Real-time monitoring of the influenza vaccine field effectiveness.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
199. AMORIM MJ , Digard P
     Influenza A virus and the cell nucleus.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
200. VIBOUD C , Tam T, Fleming D, Handel A, et al
     Transmissibility and mortality impact of epidemic and pandemic influenza, with emphasis on the unusually deadly 1951 epidemic.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
201. HAK E , Meijboom MJ, Buskens E
     Modelling the health-economic impact of the next influenza pandemic in The Netherlands.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
202. LU B , Zhou H, Chan W, Kemble G, et al
     Single amino acid substitutions in the hemagglutinin of influenza A/Singapore/21/04 (H3N2) increase virus growth in embryonated chicken eggs.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
203. NICHOL KL
     Heterogeneity of influenza case definitions and implications for interpreting and comparing study results.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
204. MUNSTER VJ , Veen J, Olsen B, Vogel R, et al
     Towards improved influenza A virus surveillance in migrating birds.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
205. FERRARIS O , Kessler N, Valette M, Lina B, et al
     Evolution of the susceptibility to antiviral drugs of A/H3N2 influenza viruses isolated in France from 2002 to 2005.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
206. IMAI M , Ninomiya A, Minekawa H, Notomi T, et al
     Development of H5-RT-LAMP (loop-mediated isothermal amplification) system for rapid diagnosis of H5 avian influenza virus infection.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
207. IORIO AM , Camilloni B, Basileo M, Guercini F, et al
     Influenza vaccination in patients on long-term anticoagulant therapy.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
208. COX RJ , Haaheim LR, Ericsson JC, Madhun AS, et al
     The humoral and cellular responses induced locally and systemically after parenteral influenza vaccination in man.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
209. BARR IG , McCaig M, Durrant C, Shaw R, et al
     The rapid identification of human influenza neuraminidase N1 and N2 subtypes by ELISA.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
210. BEYER WE
     Heterogeneity of case definitions used in vaccine effectiveness studies-And its impact on meta-analysis.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
211. VAN DER SANDE MA , Ruijs WL, Meijer A, Cools HJ, et al
     Use of oseltamivir in Dutch nursing homes during the 2004-2005 influenza season.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
212. WALLENSTEN A , Munster VJ, Karlsson M, Lundkvist A, et al
     High prevalence of influenza A virus in ducks caught during spring migration through Sweden.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
213. BRAGSTAD K , Jorgensen PH, Handberg KJ, Fomsgaard A, et al
     An emerging avian influenza A virus H5N7 is a genetic reassortant of highly pathogenic genes.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
214. BERKHOFF EG , de Wit E, Geelhoed-Mieras MM, Boon AC, et al
     Fitness costs limit escape from cytotoxic T lymphocytes by influenza A viruses.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
215. SALLERAS L , Dominguez A, Pumarola T, Prat A, et al
     Effectiveness of virosomal subunit influenza vaccine in preventing influenza-related illnesses and its social and economic consequences in children aged 3-14 years: A prospective cohort study.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
216. VANLANGENDONCK C
     Chapter II: Conclusions of the workshops of the Second European Influenza Conference.
     Vaccine. 2006;.
     PubMed     Related articles   
     
     
     
217. MEIJER A , Brown C, Hungnes O, Sc